Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities
Net loss	$ (38,861)	$ (40,656)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment	197	245
Amortization of platform development and intangible assets	13,996	13,087
Amortization of debt discounts	1,645	934
Noncash and accrued interest	602	69
Loss on impairment of assets	119	257
Change in fair value of contingent consideration	409
Liquidated damages	304	300
Stock-based compensation	12,616	16,466
Deferred income taxes	73	(1,782)
Bad debt expense	54	372
Other		185
Change in operating assets and liabilities net of effect of business combination:
Accounts receivable, net	2,213	(83)
Subscription acquisition costs	(7,273)	2,143
Royalty fees		7,500
Prepayments and other current assets	(7,327)	264
Other long-term assets	8	13
Accounts payable	742	335
Accrued expenses and other	(800)	(7,131)
Unearned revenue	5,526	945
Subscription refund liability	45	(693)
Operating lease liabilities	(114)	(107)
Other long-term liabilities	(574)	(128)
Net cash used in operating activities	(16,400)	(7,465)
Cash flows from investing activities
Purchases of property and equipment		(379)
Capitalized platform development	(2,132)	(2,784)
Proceeds from sale of equity investment		2,450
Payments for acquisition of business, net of cash acquired	(500)	(9,481)
Net cash used in investing activities	(2,632)	(10,194)
Cash flows from financing activities
Proceeds (repayments) under line of credit, net borrowing	815	(4,180)
Proceeds from common stock registered direct offering	11,500
Payments of issuance costs from common stock registered direct offering	(167)
Proceeds from common stock public offering, net of offering costs		32,058
Payments of issuance costs from common stock public offering		(1,568)
Payment of deferred cash payments	(75)	(453)
Payment of taxes from common stock withheld	(1,423)	(556)
Payment of restricted stock liabilities		(2,152)
Net cash provided by financing activities	10,650	23,149
Net increase (decrease) in cash, cash equivalents, and restricted cash	(8,382)	5,490
Cash, cash equivalents, and restricted cash – beginning of period	14,373	9,851
Cash, cash equivalents, and restricted cash – end of period	5,991	15,341
Cash, cash equivalents, and restricted cash
Cash and cash equivalents	5,489	14,839
Restricted cash	502	502
Total cash, cash equivalents, and restricted cash	5,991	15,341
Supplemental disclosure of cash flow information
Cash paid for interest	7,140	4,323
Cash paid for income taxes	85
Noncash investing and financing activities
Reclassification of stock-based compensation to platform development	548	1,125
Issuance cost of offerings recorded in accrued expenses and other	189
Issuance of common stock in connection with settlement of liquidated damages	499	7,008
Issuance of common stock upon conversion of series H preferred stock	1,500	511
Issuance of common stock in connection with acquisition	2,000
Deferred cash payments recorded in connection with acquisitions	246	1,889
Common stock issued in connection with acquisition of Athlon		3,141
Assumptions of liabilities in connection with acquisition of Athlon		12,642
Reclassification to liability upon common stock modification	$ 68